FDA Warns Companies Over Illegal Marketing Of Botox
In November 2025, the U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, commonly called Botox. The FDA is aware of adverse events associated with unapproved and misbranded botulinum toxin products[...]